Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy‐induced nausea and vomiting in pediatric cancer patients-Reference-Cited by-同舟云学术

Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy‐induced nausea and vomiting in pediatric cancer patients

Published:2019-03-21 Issue:6 Volume:66 Page:e27690
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mora Jaume¹,Valero Miguel²,DiCristina Cara³,Jin Mandy³,Chain Anne³,Bickham Kara³^ORCID

Affiliation:

1. Department of Pediatric OncologyHospital Sant Joan de Déu Barcelona Spain

2. Department of Pediatrics, Unit of Hematology and OncologyHospital Carlos Van Buren de Valparaíso Valparaíso Chile

3. Merck & Co., Inc. Kenilworth New Jersey

Funder

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27690

Reference47 articles.

1. Acute and delayed nausea and emesis control in pediatric oncology patients

2. Survey Ranking of Emetogenic Control in Children Receiving Chemotherapy

3. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice

4. Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

5. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

2. Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trial;Translational Pediatrics;2024-01

3. The clinical research study for fosaprepitant to prevent chemotherapy-induced nausea and vomiting: A review;Advances in Clinical and Experimental Medicine;2023-04-07

4. Optimizing antiemetic therapy for children undergoing chemotherapy;Journal of Pediatric Nursing;2022-09

5. Chemotherapy-induced nausea and vomiting in children – the missing evidence;Adverse Drug Reaction Bulletin;2021-06